Thank you for your interest in the GATHER2 clinical trial. At this time, enrollment for the GATHER2 clinical trial is closed.
Enrollment in the GATHER2 study is closed. If you are a participant in the study and need to speak with someone, please contact your study site.
ZIMURA® IS AN INVESTIGATIONAL PRODUCT AND HAS NOT BEEN APPROVED BY THE FDA. SAFETY AND EFFICACY OF ZIMURA® FOR AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY HAVE NOT BEEN ESTABLISHED. PLEASE SPEAK TO YOUR DOCTOR ABOUT PARTICIPATING IN THIS TRIAL.
Zimura® (avacincaptad pegol) is a registered trademark of IVERIC bio, Inc.